During the past decade, Georgia Heart Specialists conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Georgia Heart Specialists" #1 sponsor was "Bristol-Myers Squibb" with 3 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "ARYx Therapeutics" with 1 trials sponsored and "Cardiovascular Clinical Studies" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Georgia Heart Specialists" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Georgia Heart Specialists" are "Acute Coronary Syndrome" (2 trials), "Cardiovascular Disease" (2 trials), "Congestive Heart Failure" (2 trials), "Myocardial Infarction" (2 trials) and "Acute Coronary Syndrome (ACS)" (1 trials). Many other conditions were trialed in "Georgia Heart Specialists" in a lesser frequency.

Most popular intervention types in "Georgia Heart Specialists" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Apixaban" (3 trials), "Tolvaptan" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "ATI-5923" (1 trials). Other intervention names were less common.

The vast majority of trials in "Georgia Heart Specialists" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Georgia Heart Specialists". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Georgia Heart Specialists, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Georgia Heart Specialists, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".